Global Piriformis Syndrome Market Growth (Status and Outlook) 2024-2030

Global Piriformis Syndrome Market Growth (Status and Outlook) 2024-2030

Piriformis syndrome is a rare neuromuscular condition that is caused when the piriformis muscle compresses the sciatic nerve. The piriformis muscle is a flat, band-like muscle located in the buttock near the upper region of the hip joint. Piriformis syndrome mostly occurs in adults and can affect individuals from any field and activity levels. The common causes of piriformis syndrome are considered to be trauma, spasms, and overuse injury. Additionally, according to the National Center for Biotechnology Information (NCBI), the piriformis syndrome is more prevalent in patients with pain in the lower back.

The global Piriformis Syndrome market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LPI (LP Information)' newest research report, the “Piriformis Syndrome Industry Forecast” looks at past sales and reviews total world Piriformis Syndrome sales in 2023, providing a comprehensive analysis by region and market sector of projected Piriformis Syndrome sales for 2024 through 2030. With Piriformis Syndrome sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Piriformis Syndrome industry.

This Insight Report provides a comprehensive analysis of the global Piriformis Syndrome landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Piriformis Syndrome portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Piriformis Syndrome market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Piriformis Syndrome and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Piriformis Syndrome.

The North American region is anticipated to dominate the market due to the existing well-established healthcare system, increasing healthcare expenditure, growing awareness about the syndrome, and rising geriatric population.

This report presents a comprehensive overview, market shares, and growth opportunities of Piriformis Syndrome market by product type, application, key players and key regions and countries.

Segmentation by type
Medication
Physical Therapy
Others

Segmentation by application
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis
Sanofi
Bayer
AstraZeneca
Teva Pharmaceuticals
Endo Pharmaceuticals
Omron Healthcare
DePuy Synthes
Miracle Stretch
Seirin Corporation
Nidd Valley Medical

Please note: The report will take approximately 2 business days to prepare and deliver.